QuidelOrtho Corp. Stock
€40.80
Your prediction
QuidelOrtho Corp. Stock
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
Cons
Performance of QuidelOrtho Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
QuidelOrtho Corp. | 0.000% | 4.082% | 9.677% | -49.392% | -39.841% | -57.711% | - |
Boston Scientific | -1.440% | 0.000% | 3.704% | 45.258% | 36.081% | 104.141% | 106.034% |
Waters Corp. | -3.460% | -8.916% | -2.338% | 18.333% | -5.960% | 7.576% | 57.778% |
Illumina Inc. | 2.050% | -2.109% | -16.670% | -47.777% | -25.230% | -71.043% | -65.544% |
Comments
News
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s
QuidelOrtho Reports First Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and